SECTOR

Healthtech

BUSINESS DESCRIPTION

NYSE listed global digital healthcare provider working with governments, commercial organisations and healthcare providers, across the UK, US and internationally.

DATE

August 2023​

SITUATION

• Whilst generating turnover in excess of $1Bn, the business continued to be loss-making, with a monthly burn rate of $15m. The Company also required c.$200m of funding in order to reach breakeven and were unsuccessful in previous capital raising processes undertaken.

A&M ROLE AND OUTCOME

• A&M was engaged to support the company with a forecast review and fund-raising process. ​

• Our scope also extended to undertake contingency planning and advise the Board of the options available.

• We assisted Management in launching a Group and UK sales process, approaching both Trade and Special Situations investors.

• The A&M Special Situations process resulted in the sale of the UK business via a pre-packaged sale to eMed LLC. ​